<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35088872</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1651-2057</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><PubDate><Year>2022</Year><Month>Feb</Month><Day>08</Day></PubDate></JournalIssue><Title>Acta dermato-venereologica</Title><ISOAbbreviation>Acta Derm Venereol</ISOAbbreviation></Journal><ArticleTitle>Clinical Course of Atopic Dermatitis in an Adult with Amyotrophic Lateral Sclerosis: Aetiological Implications of Voluntary Movements and Dermatitis Severity.</ArticleTitle><Pagination><StartPage>adv00644</StartPage><MedlinePgn>adv00644</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1121</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2340/actadv.v102.1121</ELocationID><Abstract><AbstractText>is missing (Short communication).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kiyohara</LastName><ForeName>Tatsushi</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Fukudome</LastName><ForeName>Takayasu</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Kamio</LastName><ForeName>Yoshiyuki</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Koike</LastName><ForeName>Yuta</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Murota</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1, Sakamoto, Nagasaki city, 852-8501 Nagasaki, Japan. h-murota@nagasaki-u.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Sweden</Country><MedlineTA>Acta Derm Venereol</MedlineTA><NlmUniqueID>0370310</NlmUniqueID><ISSNLinking>0001-5555</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003876" MajorTopicYN="Y">Dermatitis, Atopic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004485" MajorTopicYN="Y">Eczema</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>28</Day><Hour>8</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35088872</ArticleId><ArticleId IdType="pmc">PMC9558317</ArticleId><ArticleId IdType="doi">10.2340/actadv.v102.1121</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Katoh N, Ohya Y, Ikeda M, Ebihara T, Katayama I, Saeki H, et al. . Clinical practice guidelines for the management of atopic dermatitis 2018. J Dermatol 2019; 46: 1053&#x2013;1101.</Citation><ArticleIdList><ArticleId IdType="pubmed">31599013</ArticleId></ArticleIdList></Reference><Reference><Citation>Mack MR, Kim BS. The itch-scratch cycle: a neuroimmune perspective. Trends Immunol 2018; 39: 980&#x2013;991.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8896504</ArticleId><ArticleId IdType="pubmed">30471983</ArticleId></ArticleIdList></Reference><Reference><Citation>Appel SH, Beers DR, Zhao W. Amyotrophic lateral sclerosis is a systemic disease: peripheral contributions to inflammation-mediated neurodegeneration. Curr Opin Neurol 2021; 34: 765&#x2013;772.</Citation><ArticleIdList><ArticleId IdType="pubmed">34402459</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber AK, Giles DA, Segal BM, Irani DN. An emerging role for eotaxins in neurodegenerative disease. Clin Immunol 2018; 189: 29&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">27664933</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakai K, Yoneda K, Moriue T, Hosokawa Y, Yokoi I, Kubota Y. Unilateral palm pompholyx in a patient with amyotrophic lateral sclerosis. Eur J Dermatol 2011; 21: 445&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pubmed">21561836</ArticleId></ArticleIdList></Reference><Reference><Citation>Troilius A, M&#xf6;ller H. Unilateral eruption of endogenous eczema after hemiparesis. Acta Derm Venereol 1989; 69: 256&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pubmed">2566236</ArticleId></ArticleIdList></Reference><Reference><Citation>Azimi E, Lerner EA, Elmariah SB. Altered manifestations of skin disease at sites affected by neurological deficit. Br J Dermatol 2015; 172: 988&#x2013;993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4326606</ArticleId><ArticleId IdType="pubmed">25132518</ArticleId></ArticleIdList></Reference><Reference><Citation>Clos AL, Kayed R, Lasagna-Reeves CA. Association of skin with the pathogenesis and treatment of neurodegenerative amyloidosis. Front Neurol 2012; 3: 5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3262151</ArticleId><ArticleId IdType="pubmed">22319507</ArticleId></ArticleIdList></Reference><Reference><Citation>Murota H, Katayama I. Exacerbating factors of itch in atopic dermatitis. Allergol Int 2017; 66: 8&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">27863904</ArticleId></ArticleIdList></Reference><Reference><Citation>Thyssen JP, Rinnov MR, Vestergaard C. Disease mechanisms in atopic dermatitis: a review of aetiological factors. Acta Derm Venereol 2020; 100: adv00162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9189753</ArticleId><ArticleId IdType="pubmed">32412642</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen HH, Akiyama T, Nattkemper LA, van Laarhoven A, Elberling J, Yosipovitch G, Arendt-Nielsen L. Alloknesis and hyperknesis-mechanisms, assessment methodology, and clinical implications of itch sensitization. Pain 2018; 159: 1185&#x2013;1197.</Citation><ArticleIdList><ArticleId IdType="pubmed">29659469</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>